High‐resolution definition of humoral immune response correlates of effective immunity against HIV

March 26, 2018

Authors: Alter G, Dowell KG, Brown EP, Suscovich TJ, Mikhailova A, Mahan AE, Walker BD, Nimmerjahn F, Bailey-Kellogg C, Ackerman ME. High-resolution definition of humoral immune response correlates of effective immunity against HIV. Mol Syst Biol. 2018 Mar 26;14(3):e7881. doi: 10.15252/msb.20177881. PMID: 29581149; PMCID: PMC5868198.

Journal: Molecular Systems Biology

Journal Abstract/ Summary:  Defining correlates of immunity by comprehensively interrogating the extensive biological diversity in naturally or experimentally protected subjects may provide insights critical for guiding the development of effective vaccines and antibody‐based therapies. We report advances in a humoral immunoprofiling approach and its application to elucidate hallmarks of effective HIV‐1 viral control. Systematic serological analysis for a cohort of HIV‐infected subjects with varying viral control was conducted using both a high‐resolution, high‐throughput biophysical antibody profiling approach, providing unbiased dissection of the humoral response, along with functional antibody assays, characterizing antibody‐directed effector functions such as complement fixation and phagocytosis that are central to protective immunity. Profiles of subjects with varying viral control were computationally analyzed and modeled in order to deconvolute relationships among IgG Fab properties, Fc characteristics, and effector functions and to identify humoral correlates of potent antiviral antibody‐directed effector activity and effective viral suppression. The resulting models reveal multifaceted and coordinated contributions of polyclonal antibodies to diverse antiviral responses, and suggest key biophysical features predictive of viral control.

June 3, 2025
The World Vaccine Congress Europe 2025
June 2, 2025
Festival of Biologics
June 1, 2025
The Fc-Mediated Effector Function Summit
May 31, 2025
Authors: Kaplonek P, et al. Sci Transl Med. 2022 May 18;14(645):eabm2311.
May 31, 2025
Authors: Hawman, David W. et al. eBioMedicine, Volume 115, 105698
May 12, 2025
Authors: Crescioli, S, Jatiani, S, & Moise, L, (2025). mAbs, 17(1). Journal: mAbs
By Abigail Harris October 8, 2024
Woburn, MA / Newark, DE – October 1st, 2024 - SeromYx Systems, a cutting-edge immunology technology company, and ACROBiosystems, a leading provider for life science solutions and tools, are excited to announce the release of their joint study on the...
October 1, 2024
Authors: P. Hsueh, M. Friedman, S. Jatiani (2024) Application Note
August 1, 2024
Authors: SeromYx Team (2024) White Paper
More Posts →